Santella offers a sustainable and innovative solution: a targeted probiotic live vaccine specifically designed to combat avian pathogenic E. coli in poultry. The vaccine boosts the immune response and enhances gut health, ultimately reducing the need for antibiotics. The global poultry industry seeks alternatives to antibiotics also driven by consumer demand.

Our vaccine represents a scalable, cost-effective solution that can be integrated into existing poultry farming practices, with strong appeal to producers aiming to improve flock health and profitability

Meet the Team

Sabrina Stoeckli

Sabrina Stöckli, MSc

Co-Founder

An accomplished professional with expertise in microbiology and immunology, complemented by a solid foundation in business administration. Brings 1.5 years of valuable experience in the pharmaceutical industry, bridging science and business to drive impactful results.

SNSF BRIDGE PoC Fellow
Olivier Schaeren

Olivier Schären, PhD

Co-Founder

An expert with over 8 years of experience in gut microbiology and a proven scientific track record. Driven by a passion for translating innovative ideas from the laboratory into real-world applications.

UniBe Venture Fellow & NCCR Microbiomes TT Fellow
Sigi Hapfelmeier

Prof. Siegfried Hapfelmeier

Scientific Advisor

Associate Professor at the University of Bern and Head of the Gut Microbiology Lab at the Institute for Infectious Diseases. A recognized expert in medical microbiology and immunology, leading innovative research in the field.

Supported By:

unibe-logo ifik-logo nccr-logo be-advanced-logo bridge-logo ivi-logo